https://www.selleckchem.com/products/dx3-213b.html
get for CCA immunotherapy but also provides new ideas for researchers to explore the immunotherapy of various tumors. CD86 has great potential to be a new target of immunotherapy by regulating cancer immune response. However, it remains unclear whether CD86 is a friend or foe in lower-grade glioma (LGG). The prognostic value of CD86 expression in pan-cancer was analyzed using Cox regression and Kaplan-Meier analysis with data from the cancer genome atlas (TCGA). Cancer types where CD86 showed prognostic value in overall survival and di
Me gusta
Comentario
Compartir
